Total lymphoid irradiation for pretransplant immunosuppression and recurrence of focal segmental glomerulosclerosis [2]

Transplant International

Volumn 21, Issue 3, 2008, Pages 286-289

  Villar, Rosangela C ^a   Chocair, Pedro R ^a   Nadalin, Wladimir ^a   Ianhez, Luiz E ^a   Tzanno Martins, Carmen ^a   Duarte, Alberto J S ^a   Vasconcelos, Dewton M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

B LYMPHOCYTE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG TOLERANCE; FOCAL GLOMERULOSCLEROSIS; HUMAN; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; LETTER; LYMPH NODE IRRADIATION; NEPHROTIC SYNDROME; PLASMAPHERESIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; T LYMPHOCYTE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSION; LYMPHATIC IRRADIATION; MALE; MIDDLE AGED; PREOPERATIVE CARE; RECURRENCE;

EID: 38849173693     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00594.x     Document Type: Letter

References (23)

1. Abbott KC, Sawyers ES, Oliver JD, et al. Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis 2001 37 : 366.
2. Savin VJ, Mccarthy ET, Sharma M. Permeability factors in focal segmental glomerulosclerosis. Semin Nephrol 2003 23 : 147.
3. Dantal J, Baatard R, Hourmant M. Recurrent nephrotic syndrome following renal transplantation in patients with focal glomerulosclerosis. Transplantation 1991 52 : 827.
4. Kemper MJ, Wolf G, Muller-Wiefel DE. Transmission of glomerular permeability factor from a mother to her child. N Engl J Med 2001 344 : 386.
5. Le Berre L, Godfrin Y, Gunther E, et al. Extra renal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. J Clin Invest 2002 109 : 491.
6. Koyama A, Fujisaki M, Kobayashi M, et al. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 1991 40 : 453.
7. Dantal J, Godfrin Y, Koll R, et al. Antihuman immunoglobulin affinity immunoabsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 1998 9 : 1709.
8. Pescovitiz MD, Book BK, Sidner RA. Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 2006 354 : 1961.
9. Ingulli E, Tejani A, Butt KM, et al. High-dose cyclosporine therapy in recurrent nephrotic syndrome following renal transplantation. Transplantation 1990 49 : 219.
10. Kershaw DB, Sedman AB, Kelsch RC, et al. Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamid. Clin Transplant 1994 8 : 546.
11. Ghiggeri GM, Carraro M, Vicenti F. Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy. Nephrol Dial Transplant 2004 19 : 1036.
12. Gohh RY, Yango AF, Morrisey PE, et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005 5 : 2907.
13. Ferguson RM, Sutherland DER, Kim T, Simmons RL, Najarian JS. The in vitro assessment of the immunosuppressive effect of fractionated total lymphoid irradiation in renal allotransplantation. Transplant Proc 1981 3 : 1673.
14. Kuruvila CK, Mccalmon RT, Schreider DP, Kortz WJ. Total lymphoid irradiation for pretransplant immunosuppression: nine year follow-up. Kidney Int 1997 61 (Suppl. 61 S89.
15. Keogh AM, Arnold RH, McDonald PS, Hawkins RC, Morgan GW, Spratt PM. A randomized trial of tacrolimus (FK506) versus total lymphoid irradiation for the control of repetitive rejection after cardiac transplantation. J Heart Lung Transplant 2001 12 : 1332.
16. Genovese MC, Uhrin Z, Bloch DA, et al. Long term follow-up of patients treated with total lymphoid irradiation for lupus nephritis. Arthritis Rheum 2002 46 : 1014.
17. Donnemberg AD, Margolick JB, Donnemberg VS. Lymphopoesis apoptosis and immune amnesia. Ann N Y Acad Sci 1995 770 : 213.
18. Tejani A, Stablein DH. Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1992 2 (Suppl. 12 s256.
19. Baum MA, Stablein DM, Panzarino VM, Tejani A, Harmon WE, Alexander SR. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001 59 : 328.
20. Kim E, Striegel J, Kim Y. Recurrence of steroid resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejection. Kidney Int 1994 45 : 1440.
21. Zucker K, Rosen A, Tsaroucha A, et al. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. Transpl Immunol 1997 5 : 225.
22. Hazzan M, Labalette M, Copin MC, et al. Preditive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate Mofetil: results from a prospective, randomized trial. J Am Soc Nephrol 2005 16 : 2509.
23. Fujisawa M, IIjima K, Ishimura T, et al. Long term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation. Pediatr Nephrol 2002 17 : 165.